| BrowserMedia Increases Biotech Foothold with MaxCyte Launch |
 |
BrowserMedia  |
For Immediate Release
BrowserMedia Increases Biotech Foothold with MaxCyte Launch
Washington, DC, Wednesday, April 24, 2002, BrowserMedia (www.browsermedia.com), a web design and software development company, announced today that they have added another biotechnology company to their roster of clients. Rockville-based MaxCyte develops targeted therapeutic products to solve severe and chronic diseases, including cancer, serious infections, cardiovascular disease and genetic disorders. Biotechnology powerhouse EntreMed (Nasdaq: ENMD) formed MaxCyte in 1999 with the goal of making cell-based delivery of therapeutics a reality. When MaxCyte needed a website developed, they approached BrowserMedia based on their reputation and biotechnology industry experience. The site went from concept to reality in less than two months and can be found at http://www.maxcyte.com.
Kerry Gunther, the President and CEO of BrowserMedia says, "We are pleased to have developed a relationship with MaxCyte and look forward to working with other biotech companies in the area."
About BrowserMedia:
BrowserMedia, LLC, (www.browsermedia.com) is a web and software development company based in Bethesda, MD. BrowserMedia leverages cutting-edge technologies to create custom web and software applications for companies serious about dominating their industry. BrowserMedia's full-services include cutting-edge design, interactive programming, marketing, and maintenance for the life-cycle of our products. Some clients include: BuyDomains.com, LightWave Communications, the New York Biotechnology Association, Verio Interactive, and The American Red Cross.
About MaxCyte:
MaxCyte, (www.maxcyte.com) is a biotechnology company developing and marketing a platform technology for rapidly loading bioactive molecules into human cells for therapeutic applications. Through partnerships with the world's leading biopharmaceutical companies, we leverage our proprietary technology to yield commercially viable therapeutic products. MaxCyte is a subsidiary of EntreMed (Nasdaq: ENMD).
Kerry F. Gunther
President, BrowserMedia
http://www.browsermedia.com
301.656.1144 x150 (v)
301.656.2772 (f)
# # # |
|
| |
| More Recent Press Releases by this Firm |
| BrowserMedia Launches Golfing Website, TrackMyRound.com |
| BrowserMedia - 05 January 2004 |
| BrowserMedia Launches Website for the American Society of Plastic Surgeons |
| BrowserMedia - 22 July 2003 |
| MacroMedia Publishes BrowserMedia ColdFusion MX Article |
| BrowserMedia - 16 June 2003 |
| Full List >> |
|
| |
| Press Releases by Firm |
|
|
| |
| Press Releases by Date |
|
|
|